Список проголосовавших за комментарий " Gapping up<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>CIDM</strong> +15.7%, <strong>IOTS</strong> +12.7%, <strong>WIX</strong> +7.5%, <strong>SODA</strong> +7.2%, <strong>IVTY</strong> +5.8%, <strong>SEDG</strong> +5.5%, <strong>ANGI</strong> +4.6%, <strong>ELOS</strong> +4.3%, <strong>CCS</strong> +3.9%, <strong>ALKS</strong> +3.5%</li><li><strong>ADI</strong> +3.5%, <strong>OZM</strong> +3.3%, <strong>IOSP</strong> +3%, <strong>A</strong> +2.7%, <strong>FANG</strong> +2.4%, <strong>PBPB</strong> +2.4%, <strong>HUN</strong> +2.3%, <strong>VNOM</strong> +2.2%, <strong>BG</strong> +1.9%, <strong>SHOP</strong> +1.7%, <strong>ADHD</strong> +1.7%, <strong>DVN</strong> +1.4%</li><li><strong>KRNT</strong> +1.4%, <strong>WGBS</strong> +1.4%, <strong>HUM</strong> +0.7%, <strong>PAAS</strong> +0.7%, <strong>ETR</strong> +0.6%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>FIG</strong> +28.2% (SoftBank confirms plans to acquire Fortress Investment Group for $3.3 bln)</li></ul><p><strong>Select EU financial related names showing strength</strong>:</p><ul><li><strong>DB</strong> +1.6%, <strong>CS</strong> +1.1%, <strong>BCS</strong> +0.9%, <strong>LYG</strong> +0.9%, <strong>HSBC</strong> +0.7%</li></ul><p><strong>Select Airline related names showing strength</strong>:</p><ul><li><strong>LUV</strong> +2.8%, <strong>UAL</strong> +2.6%, <strong>AAL</strong> +2.5%, <strong>DAL</strong> +2%, <strong>JBLU</strong> +1.4%, <strong>SAVE</strong> +1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>PAH</strong> +3.2% (Elliott Management discloses new position)</li><li><strong>PG</strong> +2.5% (Nelson Peltz's Trian takes stake)</li><li><strong>SIRI</strong> +2.3% (new Berkshire Hathaway stake)</li><li><strong>TWTR</strong> +2.2% (CEO Jack Dorsey disclosed purchase of nearly 426K shares worth $7 mln)</li><li><strong>ARDX</strong> +2.2% (reports its Phase 3 trial evaluating tenapanor as a treatment for hyperphosphatemia in patients with end-stage renal disease who are on dialysis met its primary endpoint and was generally well-tolerated)</li><li><strong>NTCT</strong> +1.2% (ValueAct new position),</li><li><strong>FOLD</strong> +1.1% (reports new positive data analyses for the oral small molecule pharmacological chaperone migalastat HCl for Fabry disease)</li><li><strong>CRM</strong> +1% (new Corvex stake)</li><li><strong>MON</strong> +1% (new Berkshire Hathaway stake)</li><li><strong>HTZ</strong> +0.9% (Icahn increases stake)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>RH</strong> +3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)</li><li><strong>OLED</strong> +2.2% (initiated with a Positive at Susquehanna; tgt $100)</li><li><strong>BBVA</strong> +2% (upgraded to Overweight from Neutral at JP Morgan)</li><li><strong>PH</strong> +1.5% (upgraded to Buy from Neutral at BofA/Merrill)</li><li><strong>V</strong> +0.6% (initiated with Buy ratings at Loop Capital)</li><li><strong>NDSN</strong> +0.5% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)</li></ul>"